不同免疫状态慢性HBV感染患者的T淋巴细胞及NKG2D表达差异研究

肝脏 ›› 2020, Vol. 25 ›› Issue (2): 131-134.

不同免疫状态慢性HBV感染患者的T淋巴细胞及NKG2D表达差异研究

王贤, 林涛发, 詹志瑜, 王少扬

350003 福州联勤保障部队第九〇〇医院感染科

收稿日期:2019-07-16 出版日期:2020-02-29 发布日期:2020-03-26
通讯作者: 王少扬,Email: wsyang2005@163.com
基金资助:
联勤保障部队九〇〇医院创新团队项目(2014cxtd05)

Differential expression of T lymphocyte and NK G2D in patients with chronic HBV infection in different immune states

WANG Xian, LIN Tao-fa, ZHAN Zhi-yu, WANG Shao-yang

Department of Infectious Diseases, The 900th Hospital of Joint Logistic Support Force PLA. Fuzhou, Fujian 350003,China

Received:2019-07-16 Online:2020-02-29 Published:2020-03-26
Contact: WANG Shao-yang, Email: wsyang2005@163.com

摘要/Abstract

摘要： 目的探讨慢性HBV感染者在不同免疫状态下的T淋巴细胞及自然杀伤细胞G2D(NKG2D)表达差异。方法根据免疫状态的不同将80例慢性HBV感染患者分为免疫耐受组(28例)、免疫清除组(30例)、低(非)复制组(22例),另选取30名健康体检者作为对照组。对4组研究对象进行外周血T淋巴细胞亚群、NK细胞、NKG2D细胞频率及血清肿瘤坏死因子-α(TNF-α)、γ干扰素水平检测。结果 4组研究对象的CD3⁺T淋巴细胞百分比,差异均无统计学意义(P>0.05)。免疫清除组的CD4⁺T淋巴细胞、CD4⁺/CD8⁺、NK细胞百分比分别为(30.14±5.36)%、(1.10±0.33)%、(9.67±4.31)%,均显著低于另外三组,CD8⁺T淋巴细胞、NKG2D⁺/NK细胞百分比分别为(33.56±5.37)%、(12.96±3.42)%,均显著高于另外三组(P<0.05)。免疫耐受组和低(非)复制组的NKG2D⁺/NK细胞百分比分别为(3.46±1.15)%和(3.55±1.07)%均显著低于对照组,免疫清除组的NKG2D+/NK细胞百分比显著高于对照组(P<0.05)。免疫清除组的TNF-α、γ干扰素水平分别为(69.62±16.46)ng/L和(69.85±12.30)ng/L,均显著高于免疫耐受组、低(非)复制组及对照组(P<0.05)。免疫耐受组、低(非)复制组及对照组的TNF-α、γ干扰素水平比较,差异均无统计学意义(P>0.05)。结论慢性HBV感染患者在不同免疫状态下,外周血淋巴细胞及NKG2D细胞表达有明显差异,临床可通过测定HBV感染者外周血T淋巴细胞、NKG2D细胞水平来评估患者的免疫状态,指导临床治疗。

关键词: 乙型肝炎病毒, 免疫状态, 自然杀伤细胞, 淋巴细胞亚群

Abstract: Objective To investigate the difference of T lymphocyte and natural killer cell G2D (NKG2D) expression in chronic HBV infected persons under different immune conditions. Methods Eighty patients with chronic HBV infection were divided into immune tolerance group (28 cases), immune clearance group (30 cases) and low (non) replication group (22 cases) according to the different immune status. Another 30 healthy people were selected as control group. Peripheral blood T lymphocyte subsets, NK cells, NKG2D cell frequencies and serum levels of tumor necrosis factor-alpha (TNF-α) and interferon-γ were measured among four groups. Results The percentage of CD3⁺ T cells in the four groups was not statistically significant (P>0.05). The percentage of CD4⁺, CD4⁺/CD8⁺, NK cells in the immune clearance group were (30.14±5.36) %, (1.10±0.33)%, (9.67±4.31)%, which were significantly lower than the other three groups. The percentage of CD8⁺, NKG2D⁺/NK cells were (33.56±5.37)%, (12.96±3.42)%, which were significantly higher than the other three groups (P<0.05). The percentage of NKG2D⁺/NK cells in immune tolerance group and low (non) replication group were (3.46±1.15)% and (3.55±1.07)% respectively, which were significantly lower than that in control group, and the percentage of NKG2D⁺/NK cells in immune clearance group was significantly higher than that in control group (P<0.05). The levels of TNF-α and IFN-γ in immune clearance group were (69.62±16.46) ng/L and (69.85±12.30) ng/L respectively, which were significantly higher than those in immune tolerance group, low (non) replication group and control group (P<0.05). There was no significant difference in the levels of TNF-α and IFN-γ between the immune tolerance group, the low (non) replication group and the control group (P>0.05). Conclusion The expression of peripheral blood lymphocyte and NKG2D cells in patients with chronic HBV infection is significantly different under different immune conditions. The immune status of patients can be evaluated by measuring the levels of peripheral blood T lymphocyte and NKG2D cells in patients with HBV infection to guide clinical treatment.

Key words: hepatitis B virus, immune status, natural killer cells, lymphocyte subsets

王贤, 林涛发, 詹志瑜, 王少扬. 不同免疫状态慢性HBV感染患者的T淋巴细胞及NKG2D表达差异研究[J]. 肝脏, 2020, 25(2): 131-134.

WANG Xian, LIN Tao-fa, ZHAN Zhi-yu, WANG Shao-yang. Differential expression of T lymphocyte and NK G2D in patients with chronic HBV infection in different immune states[J]. Chinese Hepatolgy, 2020, 25(2): 131-134.

参考文献

[1] Prajapati K, Perez C, Rojas LBP, et al. Functions of NKG2D in CD8⁺ T cells: an opportunity for immunotherapy. Cell Mol Immunol, 2018, 15:470-479.
[2] 段瑞波,刘立新. 1992-2016年我国乙型肝炎病毒携带率变化特点的Meta分析. 中华消化病与影像杂志(电子版), 2018, 8:116.
[3] 中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2015更新版). 肝脏, 2015, 20:915-932.
[4] Dou YY, Van MN, Van DBA, et al. HBV-derived synthetic long peptide can boost CD4⁺ and CD8⁺ T cell responses in chronic HBV patients ex vivo. J Infect Dis, 2018, 217:827-839.
[5] Barinov A, Galgano A, Krenn G, et al. CD4/CD8/Dendritic cell complexes in the spleen: CD8⁺ T cells can directly bind CD4⁺ T cells and modulate their response. Plos one,2017, 12:e0180644.
[6] 涂正坤.在慢性HBV感染中免疫抑制性单核细胞通过调节性NK细胞介导T淋巴细胞功能缺陷. 临床肝胆病杂志, 2017,33:2038-2038.
[7] 毛德文,王明刚. HBV相关急性肝损伤与T细胞免疫. 中国临床新医学, 2018, 11:617-621.
[8] 潘志耘曹淑凤, 黄睿,等.慢性乙型肝炎患者不同免疫状态及抗病毒治疗早期外周血NK细胞亚群变化特点. 胃肠病学和肝病学杂志, 2017, 26:444-448.
[9] 葛丹红,徐翀,姚玉峰.慢性乙型肝炎患者外周血细胞毒T细胞表面NK相关受体的表达.检验医学,2017,32:108-113.
[10] 王亚东,王玮,申川,等.慢性乙型肝炎病毒感染者不同免疫状态下自然杀伤细胞G2D表达及其活化意义. 中华传染病杂志, 2017, 35:5-10.
[11] Wang Y, Wang W, Shen C, et al. NKG2D modulates aggravation of liver inflammation by activating NK cells in HBV infection. Sci Rep, 2017, 7:88.
[12] 王亚曙, 陶琳琳. 免疫受体NKG2D及其配体介导的细胞免疫与疾病的关系. 国际儿科学杂志, 2019, 46:127-130.
[13] 林晓娥,吴景华,王宁,等.慢性乙型肝炎病毒感染者Mg²⁺转运蛋白1表达水平对CD8⁺T细胞耗竭的影响.实用医学杂志,2019,35:2070-2073,2077.
[14] 黄飞,胡勤明,贺新翔, 等.老年慢性乙肝患者炎症因子水平与α-干扰素抗病毒应答的相关性研究.实用预防医学,2017,24:743-746.
[15] 刘欣,母齐鸣,王刚等.慢性乙肝患者外周血PBMC凋亡相关因子和Th1/Th2型细胞因子的水平变化及意义.临床和实验医学杂志,2019,18:1394-1397.